On Wednesday, key officials from the firm and SK affiliates indicated that owing to market volatility, the IPO of SK pharm TECO, a California-based contract research and manufacturing organization under Korean conglomerate SK Inc., will be delayed at least until 2024. CEO of SK pharm TECO Joerg Algorism stated that the year 2024 would be "the earliest possible period" to revaluate the company's initial public offering plans. In t....
Tags : SK Pharm, TECO, IPO, Korean conglomerate,
comments (0)